Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AMEET MALLIK Insider Profile
4 Followers
AMEET MALLIK, Director at Atara Biotherapeutics, holds 929.00K shares in ADC Therapeutics (Ticker: ADCT), holds 227.50K shares in Atara Biotherapeutics (Ticker: ATRA), holds 0.00 shares in Rafael Holdings (Ticker: RFL).
AMEET MALLIK has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that AMEET MALLIK holds in companies
Most Profitable Insider Trade
The most profitable trade made by AMEET MALLIK
AMEET MALLIK's Trading History
Atara Biotherapeutics
Apr 02, 2024
Director
Uninformative Buy
―
$3.03M
Rafael Holdings
Apr 12, 2022
Director
Uninformative Sell
―
$0.00
ADC Therapeutics
Dec 09, 2024
CEO, Director
Uninformative Sell
746.01K
$1.85M
List of latest transactions for each holding click on a transaction to see AMEET MALLIK's performance on stock
You May Also Like
AMEET MALLIK insider profile FAQ
What is the percentage of profitable transactions made by AMEET MALLIK?
The percentage of profitable transactions made by AMEET MALLIK is ―.
What is the average return per transaction made by AMEET MALLIK?
The average return per transaction made by AMEET MALLIK is ―.
What stocks does AMEET MALLIK hold?
AMEET MALLIK holds: ATRA, RFL, ADCT stocks.
What was AMEET MALLIK’s latest transaction?
AMEET MALLIK latest transaction was an Uninformative Sell of $746.01K.
What was AMEET MALLIK's most profitable transaction?
AMEET MALLIK’s most profitable transaction was an Informative Sell of ADCT stock on May 9, 2024. The return on the trade was 55.50%.
What is AMEET MALLIK's role in Atara Biotherapeutics?
AMEET MALLIK's role in Atara Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.